Navigating the cardiovascular seas after allogeneic stem cell transplantation: charting a course for prevention

• by Raul Cordoba, Queralt Salas

• January 28, 2026

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

• by Kathryn Wighton

• May 27, 2026

• 5 min

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

• by Kathryn Wighton

• May 27, 2026

• 6 min

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors

• by Kausik Umanath, Jamie P. Dwyer, Robert J. Mentz

• May 29, 2026